Deepakbabu Chellapandian, MD

Permanently closed

Photos

601 5th St S Ste 320
Saint Petersburg, FL 33701
Dr. Chellapandian is the division chief of blood and marrow transplant and specializes in bone marrow transplant as a hematologist-oncologist and serves as Director of the Center for Cell and Gene Therapy for Non-Malignant Conditions (CCGNC) in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. He joined the hospital staff in 2017. Dr. Chellapandian earned his medical degree from Madurai Medical College and then trained at Postgraduate Institute of Medical Education and Research, both in India. He completed a residency in pediatrics at Albert Einstein Medical Center in Philadelphia. Dr. Chellapandian completed a pediatric hematology-oncology and bone marrow transplantation fellowship at Hospital for Sick Children/University of Toronto and an advanced fellowship on bone marrow transplantation and cellular therapy at St. Jude Children’s Research Hospital in Memphis, Tennessee.Dr. Chellapandian's clinical and research interests include hematopoietic stem cell transplant for primary immunodeficiency, immune dysregulation disorders, sickle cell disease, thalassemia, and treatment of histiocytic disorders. He has special focus on ex-vivo graft engineering techniques and autologous gene therapy. He has adapted new methods of T- cell depletion using haploidentical transplantation to transplant patients lacking a suitable matched donor. He has numerous scientific papers and review articles published in this field.
Learn More
Owner verified
See a problem?

You might also like

S. Alex Rottgers, MD

S. Alex Rottgers, MD

Dr. S. Alex Rottgers is a pediatric plastic and craniofacial surgeon at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida. He is also an assistant professor in the Johns Hopkins Department of Plastic and Reconstructive Surgery. Dr. Rottgers received his undergraduate degree in biology and philosophy from Rice University in Houston and his medical degree from Baylor College of Medicine, graduating with highest honors. He completed his residency in plastic surgery at the University of Pittsburgh and performed a fellowship in craniofacial surgery at Harvard Medical School and Boston Children’s Hospital. Dr. Rottgers joined the Johns Hopkins faculty in 2015. He currently serves as the Johns Hopkins All Children’s Hospital Chief of Pediatric Plastic Surgery, Director of the Cleft/Craniofacial Team, and Co-director of the Vascular Anomalies Clinic in St. Petersburg.Dr. Rottgers's research interests include outcomes research of patients with cleft lip and cleft palate, craniosynostosis, and vascular anomalies. He is interested in 3-D surgical planning and modeling of the craniofacial skeleton for treating patients with deformities.Dr. Rottgers is a member of the American Cleft Palate-Craniofacial Association, the American Society of Maxillofacial Surgeons, the American Society of Craniofacial Surgery, and American Academy of Pediatrics. He is now serving as the Vice President of the Florida Cleft Palate/Craniofacial Association. Dr. Rottgers serves as a journal reviewer for Plastic and Reconstructive Surgery, the Cleft Palate-Craniofacial Journal, and PLOS ONE. He has received numerous awards for his exceptional performance, including the 2018 Johns Hopkins All Children’s Hospital Best Consulting Physician, the American Cleft Palate/Craniofacial Association Paul Black Junior Investigator Award, and the Baylor College of Medicine L. Leighton Hill Excellence in Pediatrics Award and the S. Carl Harvey Memorial Award for excellence in gross anatomy.
David William Kays, MD

David William Kays, MD

Dr. Kays is the medical director of the Center for Congenital Diaphragmatic Hernia (CDH) at Johns Hopkins All Children’s and leads the first unit in the country exclusively dedicated to these patients. He also serves as director of the extracorporeal membrane oxygenation (ECMO) program and co-director of the Fetal Diagnosis/Treatment program. He joined the medical staff in 2016. Dr. Kays has more than two decades of clinical and research leadership in the treatment of CDH, a life-threatening birth defect that affects about one in every 3,000 pregnancies. His research has focused on defining the best treatment strategies for this challenging neonatal diagnosis and contributed to significant advances in care and outcomes. Dr. Kays was previously with UF Health and Shands Children’s Hospital for more than 20 years. He was also surgeon in chief, professor of surgery and chief of the division of pediatric surgery in the University of Florida College of Medicine, Department of Surgery, where he led the ECMO and congenital diaphragmatic hernia program for over 20 years. He is the author or coauthor of more than 60 peer-reviewed original science publications and speaks nationally and internationally on CDH care and outcomes. Dr. Kays earned his medical degree from the Feinberg School of Medicine at Northwestern University. He completed a surgical residency at Strong Memorial Hospital, University of Rochester Medical Center, and then completed a pediatric surgery fellowship at Morgan-Stanley Children’s Hospital of Columbia University, New York. Dr. Kays is a fellow of the American College of Surgeons and the American Academy of Pediatrics and a member of the Children’s Oncology Group.
United StatesFloridaSaint PetersburgDeepakbabu Chellapandian, MD

Partial Data by Infogroup (c) 2025. All rights reserved.

Yext